Scarica l'app Stockscreener
8.24
0.61%
0.05
Dopo l'orario di chiusura:
8.20
-0.04
-0.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.19
Aprire:
$8.07
Volume 24 ore:
7,360
Relative Volume:
0.02
Capitalizzazione di mercato:
$15.21M
Reddito:
-
Utile/perdita netta:
$-25.56M
Rapporto P/E:
-1.5846
EPS:
-5.2
Flusso di cassa netto:
$-19.35M
1 W Prestazione:
+12.72%
1M Prestazione:
+715.84%
6M Prestazione:
+324.74%
1 anno Prestazione:
+114.03%
Intervallo 1D:
$8.04
$8.24
Intervallo di 1 settimana:
$7.1628
$9.09
Portata 52W:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Nome
Biovie Inc
Settore
Industria
Telefono
775-888-3162
Indirizzo
680 W NYE LANE, CARSON CITY
Confronta BIVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
8.24 | 15.21M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Iniziato | B. Riley Securities | Buy |
Biovie Inc Borsa (BIVI) Ultime notizie
BioVie Expands Board Amid Drug Development Momentum - TipRanks
Is BioVie Inc. a good long term investmentRobust investment performance - Autocar Professional
What drives BioVie Inc. stock priceTriple-digit growth rates - Autocar Professional
BioVie Inc. Stock Analysis and ForecastPhenomenal wealth increase - jammulinksnews.com
BioVie appoints Amy Chappell, Kameel Farag to board of directors - TipRanks
BioVie Inc. Appoints Dr. Amy S. Chappell and Kameel D. Farag to Board of Directors - Quiver Quantitative
What analysts say about BioVie Inc. stockExceptional trading results - jammulinksnews.com
New to The Street Episode #679 Airs Tonight on Fox Business Network - New Castle News
What makes BioVie Inc. stock price move sharplyFree Consultation - beatles.ru
How high can BioVie Inc. stock price go in 2025Free Stock Market Practical Discussion Forums - beatles.ru
Why BioVie Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser
How BioVie Inc. stock performs during market volatilityRisk Aware High Growth Picks - Newser
New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability - The Des Moines Register
BioVie Inc. Presents Promising Data on Bezisterim's Effects on Aging and Neurodegeneration at World Aging and Rejuvenation Conference - Nasdaq
BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference - The Manila Times
Breakthrough Alzheimer's Drug Shows Unprecedented 4-Year Biological Age Reversal in Phase 3 Trial - Stock Titan
BioVie (NASDAQ:BIVI) Stock Price Down 15.6% – Should You Sell? - Defense World
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of BioVie Inc. (BIVI) - ACCESS Newswire
BioVie To Carry Out 1-for-10 Reverse Stock Split On July 7th, 2025 - 富途牛牛
BioVie Announces 1-for-10 Reverse Stock Split - TipRanks
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V. - Foster's Daily Democrat
BioVie (BIVI) Highlights Innovative Clinical Trial at Upcoming C - GuruFocus
New to The Street Show Number 675 Airing This Saturday on Bloomberg Television Featuring FLOKI, BioVie, Arrive AI, Health In Tech, and Commercialville T.V. - AInvest
BioVie announces poster on patient-centric accessibility of SUNRISE-PD trial - TipRanks
Revolutionary Parkinson's Trial Brings Treatment Testing to Patients' HomesSee How It Works - Stock Titan
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Ad - GuruFocus
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at - GlobeNewswire
BioVie Approves Reverse Stock Split Authority - TipRanks
New to The Street’s Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Oklahoman
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - ACCESS Newswire
BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lubbock Avalanche-Journal
Two Sigma Investments LP Makes New Investment in BioVie Inc. (NASDAQ:BIVI) - Defense World
Biovie Inc Azioni (BIVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):